Literature DB >> 691199

Changes in theophylline clearance during acute illness.

S Vozeh, J R Powell, S Riegelman, J F Costello, L B Sheiner, P C Hopewell.   

Abstract

Three patients demonstrated twofold to threefold changes in total-body theophylline clearance during the course of a single hospitalization for an acute illness. These changes paralleled the changes in the patients' clinical status. Theophylline clearance decreased in one patient with worsening airway obstruction, whereas clearance increased in one patient with resolving pneumonia and in one patient with improving congestive heart failure. Total-body theophylline clearance may be unstable in acute, severe illness. Close monitoring of plasma theophylline concentration in such situations will allow appropriate dose adjustments to be made and is, therefore, indicated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 691199

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

1.  Rapid prediction of steady-state serum theophylline concentration in patients treated with intravenous aminophylline.

Authors:  S Vozeh; G Kewitz; M Wenk; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

2.  Depression of theophylline elimination following BCG vaccination.

Authors:  J D Gray; K W Renton; O R Hung
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 3.  Theophylline.

Authors:  E F Ellis
Journal:  Clin Rev Allergy       Date:  1983-03

4.  Effect of hypoxia alone or combined with inflammation and 3-methylcholanthrene on hepatic cytochrome P450 in conscious rabbits.

Authors:  J Kurdi; H Maurice; A O El-Kadi; H Ong; S Dalkara; P M Bélanger; P Souich
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 5.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  Individualizing theophylline dosage: evaluation of a single-point maintenance dose prediction method.

Authors:  J H Wilkens; H Neuenkirchen; G W Sybrecht; M Oellerich
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.

Authors:  Y Horai; T Ishizaki; T Sasaki; M Watanabe; J Kabe
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Hypoxia, arterial pH and theophylline disposition.

Authors:  M Richer; Y W Lam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

Review 9.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

10.  A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.

Authors:  S F Hurley; J J McNeil
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.